NanoString Technologies, Inc. News Releases http://investors.nanostring.com/ NanoString Technologies, Inc. News Releases en NanoString Partners with Multiple Leading Contract Research Organizations to Provide Standardized PanCancer IO 360 Data Analysis Reports http://investors.nanostring.com/news-releases/news-release-details/nanostring-partners-multiple-leading-contract-research-0 Program Extends Ability of CAP CLIA Labs to Develop a Tumor Inflammation Signature Assay to Support Translational Research by Biopharmaceutical Companies SEATTLE , May 30, 2019 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for Thu, 30 May 2019 16:01:00 -0400 NanoString Technologies, Inc. News Releases 11766 NanoString to Present at the UBS Global Healthcare Conference http://investors.nanostring.com/news-releases/news-release-details/nanostring-present-ubs-global-healthcare-conference SEATTLE , May 15, 2019 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for translational research and molecular diagnostic products, today announced that the company’s management is scheduled to present at the UBS Global Healthcare Wed, 15 May 2019 06:00:00 -0400 NanoString Technologies, Inc. News Releases 11751 NanoString Technologies Releases Operating Results for First Quarter of 2019 http://investors.nanostring.com/news-releases/news-release-details/nanostring-technologies-releases-operating-results-first-2 SEATTLE , May 09, 2019 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today reported financial results for the first quarter of 2019. First Quarter Financial Highlights Total product and Thu, 09 May 2019 16:01:00 -0400 NanoString Technologies, Inc. News Releases 11731 NanoString to Release First Quarter 2019 Financial Results and Host Conference Call on Thursday, May 9, 2019 http://investors.nanostring.com/news-releases/news-release-details/nanostring-release-first-quarter-2019-financial-results-and-host SEATTLE , April 08, 2019 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced that the Company will release first quarter 2019 financial results after the close of trading on Mon, 08 Apr 2019 16:01:00 -0400 NanoString Technologies, Inc. News Releases 11691 NanoString and Leica Biosystems to Co-Market GeoMx Digital Spatial Profiling and Leica’s BOND RX Platforms for High Throughput Spatial Analysis http://investors.nanostring.com/news-releases/news-release-details/nanostring-and-leica-biosystems-co-market-geomx-digital-spatial Combined Workflow Provides Complete Solution for Rapid, Automated, and Highly Multiplexed Profiling of Protein and RNA Biomarkers in FFPE Samples SEATTLE and NEWCASTLE UPON TYNE, UK , April 02, 2019 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools Tue, 02 Apr 2019 09:17:00 -0400 NanoString Technologies, Inc. News Releases 11686 NanoString and Abcam Enter Commercial Partnership to Provide Expanded Menu of Antibodies for GeoMx Digital Spatial Profiler http://investors.nanostring.com/news-releases/news-release-details/nanostring-and-abcam-enter-commercial-partnership-provide — Abcam to Develop Conjugated FFPE IHC Validated Antibodies Compatible with the GeoMx DSP — SEATTLE and CAMBRIDGE, UK , April 01, 2019 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, Mon, 01 Apr 2019 06:00:00 -0400 NanoString Technologies, Inc. News Releases 11681 Bio-Techne and NanoString Partner to Co-Develop Integrated Workflow for RNA Spatial Profiling http://investors.nanostring.com/news-releases/news-release-details/bio-techne-and-nanostring-partner-co-develop-integrated-workflow Integrated Workflow Combines NanoString’s GeoMx DSP High-Plex RNA Assays and Bio-Techne’s Highly Sensitive RNAscope Imaging Reagent Portfolio SEATTLE and MINNEAPOLIS , March 28, 2019 (GLOBE NEWSWIRE) -- Bio-Techne (NASDAQ:TECH), a global life sciences company providing innovative tools and Thu, 28 Mar 2019 06:00:00 -0400 NanoString Technologies, Inc. News Releases 11676 NanoString Announces Commercial Launch of GeoMx Digital Spatial Profiler at the 2019 American Association of Cancer Research Conference http://investors.nanostring.com/news-releases/news-release-details/nanostring-announces-commercial-launch-geomx-digital-spatial Complete Integrated Solution includes High-Throughput Instrument, Validated Protein & RNA Panels, and Integrated Data Analysis Software SEATTLE , March 27, 2019 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular Wed, 27 Mar 2019 06:00:00 -0400 NanoString Technologies, Inc. News Releases 11606 NanoString Highlights Record Number of nCounter and GeoMx Research Studies at 2019 American Association of Cancer Research (AACR) Conference http://investors.nanostring.com/news-releases/news-release-details/nanostring-highlights-record-number-ncounter-and-geomx-research Approximately 70 Abstracts Showcase NanoString’s Platforms, Including 13 Studies Using the GeoMx Digital Spatial Profiler SEATTLE , March 26, 2019 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic Tue, 26 Mar 2019 06:00:00 -0400 NanoString Technologies, Inc. News Releases 11601 NanoString Technologies Announces Closing of Public Offering of 5,175,000 Shares of Common Stock Including Exercise in Full of Option to Purchase Additional Shares http://investors.nanostring.com/news-releases/news-release-details/nanostring-technologies-announces-closing-public-offering-1 SEATTLE , March 25, 2019 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced the closing of its previously announced underwritten public offering of 5,175,000 shares of its Mon, 25 Mar 2019 06:00:00 -0400 NanoString Technologies, Inc. News Releases 11586